Management of Oral Candidiasis of Fungal Origin
For oral candidiasis (thrush) suspected to be of fungal origin, fluconazole 200 mg on day 1 followed by 100-200 mg daily for 7-14 days is the recommended first-line treatment for moderate to severe cases, while topical agents such as clotrimazole troches or miconazole buccal tablets are recommended for mild cases. 1, 2
Assessment and Treatment Selection Based on Severity
Mild Disease
First-line options (choose one):
Alternative options (if first-line not available/tolerated):
Moderate to Severe Disease
- First-line treatment:
Management of Fluconazole-Refractory Disease
If no improvement after 7 days of fluconazole treatment:
Second-line options (choose one):
For severe refractory cases:
Special Considerations
Immunocompromised Patients
- For HIV-infected patients, antiretroviral therapy is strongly recommended to reduce recurrent infections 2
- May require longer treatment duration and closer follow-up 1
- Systemic therapy (fluconazole) generally preferred over topical agents 1
For Recurrent Infections
- Identify and address underlying predisposing factors (xerostomia, dentures, diabetes, immunosuppression) 5, 6
- Consider chronic suppressive therapy with fluconazole 100 mg three times weekly for patients with recurrent infections 2, 1
Prevention Strategies
- Maintain good oral hygiene
- Remove and clean dentures daily
- Avoid unnecessary antibiotics when possible
- For denture stomatitis, disinfect dentures with chlorhexidine solution 7
Monitoring Response
- Improvement typically occurs within 48-72 hours
- Complete resolution usually occurs within 7-14 days
- Monitor liver function tests if azole treatment extends beyond 7-10 days 1
- If no improvement is seen after 7 days, consider:
- Alternative diagnoses
- Resistant Candida species
- Need for longer treatment duration
- Alternative antifungal agents
Common Pitfalls to Avoid
- Failing to identify and address underlying predisposing factors
- Insufficient treatment duration (should continue for at least 48 hours after symptom resolution)
- Not considering drug interactions with azole antifungals
- Overlooking the need for denture hygiene in denture wearers
- Not recognizing fluconazole-resistant species (particularly C. glabrata) that require alternative treatment 2